Document is current

Any future updates will be listed below

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13098-017-0232-2

Published Online: 2017-05-15

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark